Evidence map›Paper›PMID 34800970›Full record

ArticleThe journal of headache and pain2021

Total health insurance costs in children with a migraine diagnosis compared to a control group.

Viola Obermeier, Monika Murawski, Florian Heinen, Mirjam N Landgraf, Andreas Straube, Rüdiger von Kries, Ruth Ruscheweyh

Abstract read
In one paragraph

Article in The journal of headache and pain, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Viola ObermeierLudwig Maximilians University Munich, Institute for Social Pediatrics and Adolescent Medicine, Munich, Germany.
Monika MurawskiIFT Institut für Therapieforschung, Munich, Germany.
Florian HeinenDepartment of Pediatrics, Division of Pediatric Neurology and Developmental Medicine, Ludwig Maximilians University Hospital Munich, Munich, Germany.
Mirjam N LandgrafDepartment of Pediatrics, Division of Pediatric Neurology and Developmental Medicine, Ludwig Maximilians University Hospital Munich, Munich, Germany.
Andreas StraubeDepartment of Neurology, Ludwig Maximilians University Hospital Munich, Munich, Germany.
Rüdiger von KriesLudwig Maximilians University Munich, Institute for Social Pediatrics and Adolescent Medicine, Munich, Germany.
Ruth RuscheweyhDepartment of Neurology, Ludwig Maximilians University Hospital Munich, Munich, Germany. ruth.ruscheweyh@med.uni-muenchen.de.ORCID http://orcid.org/0000-0001-9510-7158

Funding

The Federal Joint Committee, Innovation Committee (G-BA, Innovationsfonds), 01NVF17044
6 · The paper itself

Abstract

backgroundHealth care costs of migraine constitute a major issue in health economics. Several publications analyzed health care costs for adult migraine patients, based on questionnaires or secondary (health insurance) data. Although migraine often starts already in primary school age, data on migraine related costs in children is scarce. In this paper we aimed to assess the migraine-related health care costs in 6 to 11 year old children in Germany.

methodsUsing claims data of a large German health insurer (BARMER), overall annual health care costs of 6 to 11 year old children with a diagnosis of migraine in 2017 (n = 2597) were compared to a control group of 6 to 11 year old children without a headache diagnosis between 2013 and 2017 (n = 306,926). The association of migraine and costs was modeled by generalized linear regression (Gamma regression) with adjustment for sex, age and comorbidities.

resultsChildren with migraine caused considerably higher annual per capita health care costs than children without a headache diagnosis (migraine group: € 1018, control group: € 618). Excess costs directly related to migraine amounted to € 115. The remaining excess costs were related to comorbidities, which were more frequent in the migraine group. Mental and behavioural disorders constituted the most expensive comorbidity, accounting for € 105 of the € 400 annual excess costs in the migraine group.

conclusion6 to 11 year old children with a migraine diagnosis cause significant direct and comorbidity related excess costs in the German health care system.

Indexed as

Health Care CostsMigraine DisordersAdultChildControl GroupsGermanyHeadacheHumansInsurance, HealthChildrenClaims dataHeadacheHealth care costsMigraine

Identifiers

PMID34800970
PMCPMC8605561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.